AntiHypertensives Flashcards
1
Q
MOA of Thiazide Diuretics
A
- increase the excretion of Na+ and water by blocking Na+ reabsorption
- decreases blood volume and arterial resistance
- # 1 drug choice in most cases
- for HTN or edema
2
Q
Hydrochlorothiazide
A
- aka HCTZ, thiazide diuretic
- blocks Na+ reabsorption in early segment of distal convoluted tubule
- PO only
3
Q
Chlorthalidone
A
- thiazide diuretic
- 1.5-2 times more potent as HCTZ
- PO only
4
Q
Adverse effects of thiazide diuretics
A
- hyponatremia/dehydration
- hypokalemia
- hyperuricemia
- hyperglycemia
- hyperlipidemia
- photosensitivity
- contraindicated if sulfa-allergy or CKD
5
Q
MOA of Loop Diuretics
A
- inhibit co-transport of Na+/K+/2Cl- –> increases Na+ and K+ excretion
- more diuresis than thiazides, shorter duration
- for HTN or edema
6
Q
Furosemide
A
- Loop Diuretic
- most freq. prescribed of this class
- prevents passive reabsorption of water –> profound diuresis
- PO or IV
7
Q
Bumetanide
A
- Loop diuretic
- more potent than Furosemide
- PO or IV
8
Q
Adverse Effects of Loop Diuretics
A
- Orthostatic hypotension
- electrolyte imbalance (hyponatremia, dehydration)
- hypokalemia
- hyperuricemia
- hyperglycemia
- hyperlipidemia
- photosensitivity
- ototoxicity ( esp. in IV route)
- contraindicated if sulfa-allergy
9
Q
MoA of Potassium sparing diuretics
A
- less potent than thiazides and loop diuretics
- provide modest increase in urine production with less potassium excretion
- meds often coupled with HCTZ
- for HTN or edema
10
Q
Amiloride
A
- Potassium Sparing diuretic
- MoA: directly blocks Na+/K+ pump; prevents Na+ reabsorption and K+ secretion in collecting tubule
- PO only
11
Q
Triamtrene
A
- Potassium Sparing diuretic
- directly blocks Na+/K+ pump
- mild diuresis; excretes Na+, prevents secretion of K+
- PO only
12
Q
Spironolactone or Eplerenone
A
- Potassium sparing Diuretics
- aldosterone antagonist to work in collecting duct –> Na+ excretion, K+ reabsorption
- PO only
13
Q
Adverse Effects of potassium sparing diuretics
A
- hyperkalemia (esp if in combo with ACE, ARB, or K+ supplement)
- contraindicated in patients with CKD or hyperkalemia
14
Q
Adverse effects specific to spironolactone
A
- gynecomastia in males
- abnormal vaginal bleeding
- BBW: tumorigenic
15
Q
MoA of ACE Inhibitors
A
- inhibit angiotensin I converting enzyme –> block formation of angiotensin II –> decreased angiotensin II levels
- inhibit bradykinin degradation –> increased bradykinin levels in lung (cough)
16
Q
Enalapril or Lisinopril
A
- ACE inhibitors
- Enalapril –> PO or IV
- Lisinopril –> PO
17
Q
Adverse Effects of ACE inhibitors
A
- BBW: injury/death to developing fetus
- first dose hypotension (abrupt drop of angiotensin II
- dry cough (bronchial/laryngeal irritation)
- Hyperkalemia
- Angioedema (increased permeability of capillaries, esp if IV)
18
Q
Indications of ACE inhibitors
A
- HTN
- MI
- prevention of MI, stroke, and death in patients at high risk of CVD
- CHF
19
Q
MoA of ARBs
A
- bind to angiotensin II receptor subtype –> block action of angiotensin II
- relaxes smooth muscle and promotes vasodilation
- decreases aldosterone release and increases renal Na+/water excretion
- alternate to ACEs
20
Q
Losartan or Valsartan
A
- ARBs
- both PO only
- Losartan 1st choice for this class
- higher cost, reserved for patients who develop cough with ACE inhibitors
21
Q
Indications of ARBs
A
- HTN
- MI
- CHF
- Prevention of stroke in patients with high risk of CVD
22
Q
Adverse effects of ARBs
A
- BBW: can cause injury/death to developing fetus
- no problems with cough
- hyperkalemia
- hypotension
- angioedema (rare)
- acute renal insufficiency
- additive hypotensive effects when in combo with other antihypertensives
23
Q
ACE inhibior/ARB warning
A
- start with smallest dose possible due to hypotension risk
- may cause hyperkalemia in CKD patients or patients on other K+ sparing meds
- absolutely contraindicated in pregnancy
24
Q
MoA of Renin inhibitor
A
- Inhibits angiotensinogen to angiotensin I conversion
- does not block bradykinin breakdown (less cough than ACE-Is)
25
Aliskiren
- Renin inhibitor; inhibits angiotensinogen to angiotensin I conversion
- can be used alone or in combo with other antihypertensives
- PO
26
adverse effects of Renin inhibitors
- orthostatic hypotension
- hyperkalemia
- angioedema
- BBW: injury/death to developing fetus
27
MoA of all types of CCBs
- inhibit influx of calcium via the voltage-dependent calcium channels in vascular smooth muscle
- relaxation of peripheral vasculature --> peripheral vasodilation
- each agent produces different degrees of systemic/coronary arterial vasodilation
28
Dihydropyridines
- CCBs that act primarily on artieroles
- end in (-dipine)
- ex. Nifedipine, Amlodipine, Clevidipine
29
Nifedipine
- dihydropyridine CCB, acts on arterioles
- the 1st choice of drug for this class
- more potent
- PO
30
Amlodipine
- dihydropyridine CCB, acts on arterioles
- more potent
- PO
31
Clevidipine
- dihydropyridine CCB, acts on arterioles
- IV only
32
Non-dihydropyridines
- CCBs that act on arterioles and on the heart
- inhibit influx of calcium via voltage-dependent calcium channels in vascular smooth muscle AND in th heart
- decrease HR, AV conduction, and force of contraction
33
Verapamil
- Non-dihydropyridine CCB; acts on artieroles AND heart
- PO or IV
34
Diltiazem
- Non-dihydropyridine CCB; acts on artieroles AND heart
- PO or IV
35
adverse effects of CCBs (dihydropyridines)
- dizziness, headache, flushing
- reflex tachycardia (avoided by using B-blocker in combo)
- peripheral edema
- gingival hyperplasia
36
adverse effects of CCBs (non-dihydropyridines)
- peripheral edema
- headache
- gingival hyperplasia
- CV effects (bradycardia, AV block, decrease myocardial contractility, hypotension)
- constipation
37
indications of CCBs
- HTN
- Angina pectoris (dihydro)
- cardiac dysrhythmias (non-dihydro)
38
MoA of B-Blockers
- competitively antagonize the response of catecholamines mediated by beta-receptors
- decreased heart contractility and HR
- decreased cardiac output and peripheral resistance
- decreased renin release and blood volume
39
Selective B1 blockers
- greater tendency to occupy B1 receptors in the heart rather than B2 in the lungs
- AtBM --> Atenolol, Bisoprolol, Metoprolol
40
Metoprolol
- Selective B1 blocker
- PO
41
Atenolol
- Selective B1 blocker
- PO
42
Bisoprolol
- Selective B1 blocker
- PO
43
Non-selective B1 and B2 blockers
- most adverse effects on lungs
- ex. propranolol
44
Propranolol
-Non-selective B1 and B2 blocker
- PO, IV
- prototype for this class of drugs
45
Nebivolol
- B1 selective with Nitric oxide dependent vasodilation
- PO
46
Partial agonist B blockers
- have intrinsic sympathomimetic activity --> prevents bronchoconstriction and other B-blocking actions
- ability to maintain satisfactory HR
- ex. Acebutolol
47
Acebutolol
- Partial agonist B blocker
- depresses HR less than other B blockers
- PO
48
Nonselective B blockage drugs with A blockade
- alpha blockade --> promotes vasodilation (but also orthostatic hypotension)
- B blockade on heart --> decreased HR and contractility
- B blockade on juxtaglomerular cells --> suppresses release of renin
- ex. Carvedilol, Labetolol
49
Carvedilol
- Nonselective B blockage drugs with A blockade
- PO
50
Labetolol
- Nonselective B blockage drugs with A blockade
- alternative med for chronic HTN in pregnancy
- PO, IV
51
Indications of B blockers
- HTN
- Angina
- MI
- Antiarrhythmics
- Migraine
- Glaucoma
52
Adverse effects of B blockers
- bradycardia, AV block, worsening HF
- induce/worsen bronchospasm (Asthma, some COPD)
- sexual impairment
- depression, fatigue, nightmares, confusion, hallucinations
- hyperglycemia, hyperTGemia
- allergy to propranolol
53
BBW of b blockers
- abrupt d/c may cause rebound HTN or unstable angina, MI, and death in patients with high CAD
54
MoA of alpha 1 blockers
- blocks A1 receptors (competitive antagonists) --> competes with norepinephrine and epinephrine on vascular smooth muscle and prevents vasoconstriction
- dilation of arterioles
- reduce prostatic symptoms in men
55
Terazosin
- Alpha 1 blocker
- PO
56
Tamsulosin
- Alpha 1 blocker
- selective for prostate smooth muscle vs vascular smooth muscle
- PO
57
indications for A1 blockers
- HTN
- BPH
58
adverse effects of A1 blockers
- CV: reflex tachy and ortho hypotension
- salt and water retention
- blurred vision
- nasal congestion
- erectile dysfunction
59
MoA of A2 agonist
- 2nd line agents
- selective activation of A2 receptors in the CNS --> vasodilation, reduce HR and cardiac output
60
Methyldopa
- A2 agonist
- drug of choice for chronic HTN in pregnancy
- PO
61
Clonidine
- A2 agonist
- used in resistant HTN (2nd and 3rd line agent, high side effects)
- adjunct therapy in cancer pain
- off label use for opioid/alc withdrawal symptoms, nicotine dependence, PMS
- PO
62
Indications for A2 agonists
- HTN
- ADHD
- Pain (clonidine)
63
adverse effects of A2 agonists
- CNS depression --> drowsiness
- dry mouth
- Rebound HTN --> large jump in BP occurring to abrupt clonidine withdrawal (requires slow weaning)
64
MoA of Direct Arteriolar Vasodilators
- selective dilation of arterioles (not veins)
- produce peripheral vasodilation --> decreased peripheral resistance
- increase HR/myocardial contractility by baroreceptor activation
65
Hydralyzine
- Direct Arteriolar Vasodilator
- PO or (IV in hypertensive emergencies)
- used prior to labor in pre-eclampsia
66
Minoxidil
- Direct Arteriolar Vasodilator
- not first choice drug (pericardial effusion side effects), only used for pts who do not respond to first line
- PO
67
adverse effects of arteriolar vasodilators
- reflex tachycardia
- vascular headache
- Lupus-like syndrome (hydralazine)
Specific to Minoxidil --> pericardial effusion (BBW); Hirsutism
68
drugs used in chronic HTN in pregnancy
- methyldopa
- labetolol
69
Drugs for hypertensice emergency
- nitroglycerin
- hydralyzine
- labetolol
- clevidipine
70